Gene · 4647
Papers1,877
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,877
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prevalence of Molecular Diagnoses for Usher Syndrome and the Need for Coordinated Care. | Laryngoscope | 2025 | 39560289 | PubTator, text mining | PubMed |
| FunCoup 6: advancing functional association networks across species with directed links and improved user experience. | Nucleic Acids Res | 2025 | 39530220 | PubTator, text mining | PubMed |
| Clinical and genetic characterisation of childhood-onset sensorineural hearing loss reveal associated phenotypes and enrichment of pathogenic founder mutations in the Finnish population. | Int J Audiol | 2025 | 39422539 | PubTator, text mining | PubMed |
| The clinical and genetic spectrum of paediatric speech and language disorders. | Brain | 2025 | 39412438 | PubTator, text mining | PubMed |
| A Case of Autosomal Recessive Retinitis Pigmentosa with Vitelliform-Like Appearance at the Macula Associated with Novel MYO7A Variant P.Ser383TrpfsTer64. | Beyoglu Eye J | 2024 | 40007671 | PubTator, text mining | PubMed |
| In vivo AAV9-Myo7a gene rescue restores hearing and cholinergic efferent innervation in inner hair cells. | JCI Insight | 2024 | 39641274 | PubTator, text mining | PubMed |
| Spectrum of DNA variants for patients with hearing loss in 4 language families of 15 ethnicities from Southwestern China. | Heliyon | 2024 | 39640791 | PubTator, text mining | PubMed |
| Molecular and Clinical Characterization of a Cohort of Autosomal Recessive Sensorineural Hearing Loss in Egyptian Patients. | J Mol Neurosci | 2024 | 39467922 | PubTator, text mining | PubMed |
| Reprogramming with Atoh1, Gfi1, and Pou4f3 promotes hair cell regeneration in the adult organ of Corti. | PNAS Nexus | 2024 | 39411090 | PubTator, text mining | PubMed |
| Genotype Characterization and MiRNA Expression Profiling in Usher Syndrome Cell Lines. | Int J Mol Sci | 2024 | 39337481 | PubTator, text mining | PubMed |
| A novel compound heterozygous variant of MYO7A in Usher syndrome type 1. | Exp Eye Res | 2024 | 39151776 | PubTator, text mining | PubMed |
| Genetic landscape of hearing loss in prelingual deaf patients of eastern Iran: Insights from exome sequencing analysis. | Clin Genet | 2024 | 39107234 | PubTator, text mining | PubMed |
| Zebrafish myo7aa affects congenital hearing by regulating Rho-GTPase signaling. | Front Mol Neurosci | 2024 | 39081296 | PubTator, text mining | PubMed |
| Clinical Genetic Testing for Hearing Loss: Implications for Genetic Counseling and Gene-Based Therapies. | Biomedicines | 2024 | 39062005 | PubTator, text mining | PubMed |
| A large-scale screening identified in USH2A gene the P3272L founder pathogenic variant explaining familial Usher syndrome in Sardinia, Italy. | BMC Ophthalmol | 2024 | 39044131 | PubTator, text mining | PubMed |
| Usher syndrome in the United Arab Emirates. | Ophthalmic Genet | 2024 | 39016003 | PubTator, text mining | PubMed |
| Generation of two induced pluripotent stem cell lines from an Usher syndrome type 1B patient with the homozygous c.496del MYO7A variant. | Stem Cell Res | 2024 | 39013239 | PubTator, text mining | PubMed |
| Targeted genome editing restores auditory function in adult mice with progressive hearing loss caused by a human microRNA mutation. | Sci Transl Med | 2024 | 38985856 | PubTator, text mining | PubMed |
| Adaptive optics retinal imaging in patients with usher syndrome. | Front Ophthalmol (Lausanne) | 2024 | 38984112 | PubTator, text mining | PubMed |
| Editorial: Unconventional myosins in motile and contractile functions: fifty years on the stage. | Front Physiol | 2024 | 38933364 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4647/papers?page=5